ArticlePoultry science2026
Integrating network pharmacology and in vivo evaluation reveals chicory (Cichorium intybus L.) extract activates autophagy to alleviate fatty liver hemorrhagic syndrome in laying hens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fatty liver hemorrhagic syndrome (FLHS) is a nutritional metabolic disease in poultry characterized by disrupted lipid metabolism in the liver. This study aimed to investigate the pharmacological effects and mechanisms of chicory (Cichorium intybus L.) root ethanol extract (CEE) on HELP-diet-induced FLHS. Seventy-two 50-week-old Hy-Line Brown laying hens were randomly allocated into three groups, with four replicates in each group and six hens per replicate. A standard basal diet was provided to the negative control (NC) group, whereas the other two groups were fed the high-energy low-protein (HELP) diet supplemented with 0 g/kg or 15 g/kg CEE, designated as the FLHS and CEE groups, respectively. The adaptation period lasted for 1 week, followed by a 12-week experimental period. UPLC-MS/MS-based component profiling of CEE, combined with network pharmacology analysis, identified three bioactive compounds: lactucopicrin, 2S,2'S-Aurantiamide acetate, and luteolin. Body weight was significantly increased by the HELP diet, while hens receiving CEE markedly lower body weight relative to the FLHS group at week 12 (P < 0.05 or 0.01). CEE supplementation significantly restored the laying rate, and reduced the Feed/egg ratio (P < 0.01). The FLHS group showed pronounced hepatic steatosis in laying hens, with increased TG and TC levels in serum and liver and elevated ALT and AST activities, which were markedly reversed by CEE treatment. There were 93 metabolites showing significant differences in the liver between the FLHS and CEE groups, such as 1-stearoyl-2-arachidoylglycerol, PE-NMe2, and 19-hydroxyarachidonic acid. Differentially expressed metabolites are enriched in the autophagy signaling pathway according to KEGG. CEE treatment significantly inhibited the protein levels of p-mTOR/mTOR, p62, Fasn, Acc, and Pparγ, while significantly increasing those of p-Ulk1/Ulk1, Atg5, LC3II/LC3I, and Pparα (P < 0.05 or 0.01). In conclusion, supplementation with 15 g/kg CEE effectively mitigated FLHS in laying hens by modulating hepatic lipid metabolism by activating autophagy. CEE represents a novel pharmacological strategy for FLHS treatment, highlighting chicory potential in poultry.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.